无胸痛表现的STEMI患者预后:一项全国性回顾性队列研究
无胸痛患者年龄更大、女性及华人更多、糖尿病和高血压患病率更高,接受PCI比例更低(36% vs 77%),门球时间更长(100 min vs 70 min)。校正基线因素后,无胸痛表现与30天、1年、5年和10年全因死亡风险升高独立相关。
要点
- 无胸痛STEMI患者接受PCI比例更低(36% vs 77%),门球时间更长(100 min vs 70 min)。
- 无胸痛表现与30天全因死亡风险升高独立相关(HR 2.93,95%CI 2.62–3.28)。
- 长期死亡风险持续升高:1年HR 2.80、5年HR 2.47、10年HR 2.31。
核心结论
- 校正基线危险因素和治疗后,无胸痛表现仍与更差生存结局独立相关。
主要发现
- 12.6%的首次STEMI患者无胸痛表现,该组年龄更大、女性及华人更多、从未吸烟者更多,糖尿病和高血压患病率更高。
- 无胸痛患者较少出现呼吸困难和大汗等其他可能的心脏症状,接受PCI比例更低(36% vs 77%),门球时间更长(100 min vs 70 min)。
- 校正基线危险因素和临床特征后,无胸痛表现与30天全因死亡风险升高相关(HR 2.93,95%CI 2.62–3.28)。
- 无胸痛表现与1年(HR 2.80,95%CI 2.56–3.06)、5年(HR 2.47,95%CI 2.30–2.66)和10年(HR 2.31,95%CI 2.16–2.46)全因死亡风险升高相关。
临床怎么用
- 对无胸痛但存在糖尿病、高血压等危险因素的患者,应警惕STEMI可能,避免延误再灌注治疗。
- 无胸痛STEMI患者接受PCI比例低且门球时间长,需优化急救流程以缩短再灌注延迟。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A significant proportion of patients with ST-elevation myocardial infarction (STEMI) present without cardiac symptoms of chest pain. Such presentations potentially affect the care they receive and ultimately affect these patients' short and long-term outcomes. We analysed a national acute myocardial infarction (AMI) registry to characterise the demographics, processes of care and outcomes of non-chest pain (NCP) STEMI presentations. METHODS: Retrospective data for all STEMI cases from 2007 to 2020 were analysed from the Singapore Myocardial Infarction Registry. Cases which happened during inpatient and interfacility transfers were excluded. Univariable and multivariable logistic models were used to identify factors associated with NCP presentation. Cox proportional hazard models were constructed to investigate the prognostic influence of NCP on short-term and long-term mortality outcomes. ORs and HRs were calculated along with their 95% CI. RESULTS: Among 21 858 patients with first-onset STEMI, 12.6% presented with NCP. These patients were older, more likely to be women and Chinese and had never smoked. The prevalence of diabetes and hypertension was also higher. These patients were also less likely to present with other possible cardiac symptoms of AMI, such as dyspnoea and diaphoresis. They were less likely to receive percutaneous coronary intervention (36% vs 77%) and had longer door-to-balloon times (100 min vs 70 min). After adjusting for differences in baseline risk factors and clinical characteristics, NCP presentation was associated with a higher risk of all-cause mortality at 30 days (HR 2.93, 95% CI 2.62 to 3.28), 1 year (HR 2.80, 95% CI 2.56 to 3.06), 5 years (HR 2.47, 95% CI 2.30 to 2.66) and 10 years (HR 2.31, 95% CI 2.16 to 2.46). CONCLUSION: After adjusting for baseline risk factors and treatments received, NCP presentation was still independently associated with worse survival outcomes. Further research is required to risk-stratify these patients and address the suboptimal treatment rates and outcomes.
引用
- Wong, Teo, Yau, et al. Prognosis of patients with ST-elevation myocardial infarction presenting to the emergency department without chest pain: a retrospective nationwide cohort study. Heart. 2026. PMID: 42315345. doi:10.1136/heartjnl-2025-327601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。